SUMMARY
self-antigens or apoptotic cell bodies continuously migrate to the draining lymph nodes but instead of immunity peripheral tolerance against self-antigens is maintained [1] [2] [3] . It is now apparent that DCs also tightly regulate polarization of T helper (T H ) cells [4] [5] [6] [7] .
Due to the pivotal role DCs play in controlling immunity, DC-based treatment strategies are increasingly recognized to have therapeutic potential in many immunopathological conditions including cancer, autoimmunity and allogeneic transplantation. But, until recently, difficulties in isolation and culture and the paucity of DCs in tissues have impeded their application in animal models of immune diseases or in clinical settings. During the last decade, however, numerous in vitro systems have been developed allowing the production of large quantities of DCs. Standardized protocols exist for generation of human and mouse DCs from circulating monocyte [8] [9] [10] and bone marrow or blood progenitor cells [11] [12] [13] [14] [15] . It was originally demonstrated that DCs could be successfully grown from mouse bone marrow or blood cultures supplemented with granulocyte macrophage colony-stimulating factor (GM-CSF). In contrast to the mouse system, low numbers of DCs (< 5% of the starting cell number)
were generated from rat bone marrow cells in the presence of GM-CSF [16, 17] .
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However, cells yields were dramatically increased, albeit not in the range of mouse and human BMDCs, when interleukin (IL)-4 or IL-4 plus Flt-3 ligand (FL) were used in combination with GM-CSF [18] [19] [20] . Several observations may provide a plausible explanation for this phenomenon. For example, successful generation of human DCs from blood monocytes requires the presence of IL-4 along with GM-CSF in culture medium. IL-4 has been shown to suppress macrophage outgrowth thus allowing formation of DCs from human peripheral blood [9] . It has recently been demonstrated that, while GM-CSF ensures terminal differentiation of DC precursors, FL sustains their long-term expansion [21] . In addition, GM-CSF and FL are known to increase the total DC numbers in mice and humans when administered in vivo [22] [23] [24] .
Given the ability of DCs to induce both immunity and tolerance and to regulate T H 1/T H 2 responses, opposite outcomes of DC-based treatments may be desired, depending on the nature of immune pathology. Therefore, the generation of large numbers of DCs is not per se sufficient for the development of optimal therapeutic approaches. Detailed functional characterization of in vitro propagated DCs is of utmost importance.
The objective of this study was to examine the phenotype of DCs generated from rat bone marrow cultures supplemented with GM-CSF, IL-4, and FL and, most importantly, their functional properties, such as the ability to internalize antigens, activate CD4 + T cells, and direct T H 1/T H 2 polarization. 
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MATERIALS AND METHODS
Animals
Cell culture medium and other reagents
The culture medium (R10) was RPMI 1640 supplemented with 2mM Lglutamine, 1mM sodium pyruvate, 10mM HEPES, 50µg/ml gentamicin, 
Generation of BMDCs
BMDCs were generated as described previously [15] with some modification.
Bone marrow was collected from the femurs of Fisher 344 rats, passed through a 50µm
Filcon filter (DakoCytomation, Solna, Sweden) to remove debris and clumps and resuspended at 2x10 6 cells/ml in R10s (R10 supplemented with 20ng/ml IL-4, 50ng/ml GM-CSF, and 25ng/ml FL). Bone marrow cells (10ml) were then plated into 100mm
bacteriological Petri dishes and maintained at 37°C in 5%CO2/95% air. Three days after initiation of the culture, 10ml of fresh R10s were added to each Petri dish. On day 6, 50% of the spent medium was collected, centrifuged, the cell pellet was then resuspended in 10ml fresh R10s and returned into the original Petri dish. On day 7, nonadherent and semi-adherent cells were harvested by flushing the Petri dishes with R10.
To induce maturation cells were resuspended at 1x10 6 cells/ml in R10 supplemented with 10ng/ml IL-4, 25ng/ml GM-CSF, and 0.1µg/ml LPS and replated in tissue culture plastic plates. Non-adherent mature BMDCs were harvested on day 8 for phenotypic and functional analysis.
Flow cytometry
For surface labeling 0.5x10 5 Proliferation was evaluated by calculation of the stimulation index (SI) according to the following formula:
Results were expressed as mean ± SD.
Cytokine production by T cells
A total of 1x10 6 allogeneic CD4 + T cells were cultured with 1x10 5 irradiated
BMDCs in a final volume of 1ml in 24-well plates. After 5 days of stimulation cells were harvested, washed and the cell concentration was adjusted to 0.2x10 6 cells/ml.
Cells were then restimulated in 24-well plates coated with 0.5µg/ml anti-CD3 antibody (G4.18, BD Biosciences, Stockholm, Sweden) in the presence of 2µg/ml anti-CD28
antibody (JJ319, BD Biosciences, Stockholm, Sweden) or cultured untreated in R10.
Twenty-four hours later cell culture supernatants were collected and frozen for subsequent analysis by ELISA.
ELISA
Measurements of IL-4 and IL-10 were done using BDOptEIA ELISA sets (BD Biosciences, Stockholm, Sweden) according to the manufacturer's recommendations. Europe, Nivelles, Belgium) was applied to the plates at a final concentration of 1µg/ml for 45 minutes, followed by 30 minutes incubation with 2.5µg/ml avidin-conjugated peroxidase (Sigma-Aldrich, Stockholm, Sweden). Color was developed using 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (Sigma-Aldrich, Stockholm, Sweden) and plates were read at 405 nm. All steps were performed at room temperature unless otherwise indicated. The sensitivity of the assay was 1.6pg/ml for IL-4, 15.6pg/ml for IL-10 and 31.3pg/ml for IFN-γ.
RESULTS
Phenotype of rat BMDCs
Phenotype A subpopulation of BMDCs (32.1±5.5%) stained for OX62, an alpha E2 integrin expressed by a fraction of rat DCs (Fig.1A) . Only 16.8±5.3% of BMDCs were positive for CD11c and the staining intensity was generally low (Fig.1B) . (Fig.2A) . In response to LPS treatment of BMDCs, the number of CD80 + CD86 + cells increased to 27.8±8.2% (Fig.2B) 
Endocytic capacity of rat BMDCs is downregulated during maturation
To assess the endocytic capacity of BMDCs, macropinocytosis of FITC-albumin was studied. As expected, immature BMDCs were highly endocytic compared to mature cells (Fig.3A) . Mean fluorescence intensity (MFI), which reflects the amount of FITC-albumin particles taken up by BMDCs, decreased from 193.1±34.2 in immature to 85.4±29 in mature cells (Fig.3B) .
BMDCs induce CD4 + T cell proliferation in a mixed leukocyte reaction
The ability of DCs to induce proliferation of T cells in a mixed leukocyte reaction 
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+ T cells produced large quantities of IFN-γ: 9.5±6.2ng/ml (Fig.5A) . The amount of IL-4 was much lower: 57.5±10.9pg/ml (Fig.5B) . In addition to IFN-γ and IL-4, BMDCs activated CD4 + T cells also secreted IL-10: 3.6±1.4ng/ml (Fig.5C ).
DISCUSSION
In this study we generated cells with typical DC phenotype from rat bone marrow cultures supplemented with FL, GM-CSF, and IL-4. Only few of the bone marrowderived cells expressed antigen specific markers for T, B, NK cells or macrophages.
BMDCs expressed intermediate levels of MHC II and low levels of CD80 and CD86. staining in our study were generally lower than those reported by Brissette-Storkus et al [19] . The blocking of Fc receptors prior to staining in our experiments could explain this discrepancy and warrants caution in the interpretation of previous data from flow cytometry of BMDCs. We found that a subset of MHC II + BMDCs was RK4 positive.
RK4 is rat pan granulocyte marker that binds to a cell surface antigen of unknown specificity. We were unable to use the widely accepted rat granulocyte antibody HIS48, because the IgM isotype control of the HIS48 gave a strong unspecific staining (data not shown). It has been reported that FL induces human and mouse plasmacytoid DCs in vivo and in vitro and that in some mouse strains plasmacytoid DCs express the granulocyte marker Gr-1 [25] [26] [27] [28] [29] [30] . It is at present unclear whether the MHCII + RK4 + subpopulation of BMDCs represents the rat equivalent of human and mouse plasmacytoid DCs.
To further characterize rat BMDCs a number of functional test have been performed. Immature DCs efficiently internalize antigens [31] but downregulate their ability to capture antigens during maturation [8, 32] . This study is the first to show that rat immature BMDCs have the capacity to internalize FITC-albumin, which they to a large extent loose after LPS treatment. Thus, also in the rat downregulation of endocytosis reflects the transformation of BMDCs from an immature to a mature phenotype.
We also found that mature BMDCs induced a strong proliferation of purified allogeneic CD4 + T cells at low stimulatory: target cell ratio with the SI reaching 46.9.
Interestingly, at high BMDCs numbers the SI decreased dramatically. This decrease in proliferation cannot be explained by high cell numbers in the MLR assay, since we were able to detect a SI of 180 when CD4 + T cells were stimulated with anti-CD3 and anti-CD28 antibodies (data not shown). A similar reduction in SI was observed for DCs derived from CD34 + HLA-DR2 -cells incubated with GM-CSF and TNF-α [21] . DCs generated from rat bone marrow using GM-CSF and IL-4 have been shown to be week stimulators of an allogeneic MLR [33] . However, the addition of FL to the culture medium increased the allostimulatory capacity of rat BMDCs at least 10 times [19] . It is difficult to compare the results of MLR between different studies due to the differences in the experimental procedures. Nevertheless, the highest values for 3 H-thymidine incorporation in our assay were close to data reported by Brissette-Storkus et al, although this study did not use purified CD4 + T cells.
DCs are a heterogeneous cell population. Several phenotypically distinct cell subtypes have been described in humans and mice. Although, functional plasticity is the general feature of all DC subsets some degree of specialization, yet, exists. Human monocyte-derived DCs were found to direct T H 1 differentiation, whereas DCs derived from plasmacytoid cells drive T H 2 development [6] . Two subtypes of rat DCs,
CD4
+ SIRP + and CD4 -SIRP -, have been identified in lymph from the small intestine [34] . Similar populations have been described among OX62 + DCs of rat spleen, thymus and lymph nodes [35] . This study failed, however, to detect CD8 expression on OX62 + splenic DCs. In contrast, de la Mata et al [36] reported that between 19 to 48% of spleen In addition to IFN-γ and IL-4, CD4 + T cells secreted IL-10 when activated by BMDCs. IL-10 was originally described in mice as exclusively T H 2 cytokine [40] .
However, Yssel et al [41] showed that human T H 0-and T H 1-like CD4 + T cell clones produce IL-10 at the late stages of activation. It was therefore hypothesized that, at least in humans, IL-10 acts as a negative regulator of immune responses. This interpretation was further supported by the findings that human plasmacytoid and myeloid DCs induce T H cells secreting both IFN-γ and IL-10 [42, 43] . IL-10 is also known to be produced by regulatory T cells [44, 45] . It has been recently proposed that DCs may exist in three developmental stages: immature, semi-mature and fully mature cells [46] . Results shown represent two independent experiments, three animals per experiment.
